We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Advance Auto Parts
AAP
$3.35B
| $115M | 0.26% |
663,600
+351,195
| +112% | +$69.6M |
|
77
T-Mobile US
TMUS
$185B
| $115M | 0.26% |
853,634
+240,500
| +39% | +$31.4M |
|
78
Oracle
ORCL
$374B
| $115M | 0.26% |
1,639,416
-5,800
| -0.4% | -$425K |
|
79
BioMarin Pharmaceuticals
BMRN
$11.6B
| $114M | 0.26% |
1,375,000
-100,000
| -7% | -$7.96M |
|
80
Intuit
INTU
$86.5B
| $114M | 0.26% |
294,500
-1,200
| -0.4% | -$497K |
|
81
Jazz Pharmaceuticals
JAZZ
$15.9B
| $113M | 0.26% |
725,000
+75,000
| +12% | +$11.5M |
|
82
Analog Devices
ADI
$179B
| $110M | 0.25% |
755,437
-58,500
| -7% | -$9.21M |
|
83
Medtronic
MDT
$109B
| $109M | 0.25% |
1,217,130
-11,900
| -1% | -$1.21M |
|
84
M&T Bank
MTB
$35.7B
| $107M | 0.25% |
674,069
-5,976
| -0.9% | -$1M |
|
85
Booking.com
BKNG
$149B
| $107M | 0.24% |
1,524,750
+452,250
| +42% | +$38.6M |
|
86
Lockheed Martin
LMT
$134B
| $106M | 0.24% |
247,198
-114,379
| -32% | -$50.2M |
|
87
Morgan Stanley
MS
$331B
| $106M | 0.24% |
1,387,434
-102,900
| -7% | -$8.43M |
|
|
ERF
88
DELISTED
Enerplus Corporation
ERF
| $104M | 0.24% |
7,837,762
-1,307,358
| -14% | -$18M |
|
89
MetLife
MET
$61.9B
| $103M | 0.24% |
1,644,926
-537,800
| -25% | -$35.6M |
|
90
TE Connectivity
TEL
$59.6B
| $103M | 0.24% |
910,544
+150,100
| +20% | +$18.6M |
|
91
Starbucks
SBUX
$120B
| $101M | 0.23% |
1,326,909
+125,700
| +10% | +$9.65M |
|
|
VG
92
DELISTED
Vonage Holdings Corporation
VG
| $101M | 0.23% |
5,343,769
+2,634,398
| +97% | +$50.4M |
|
93
Dover
DOV
$27.6B
| $100M | 0.23% |
824,375
+490,104
| +147% | +$66.3M |
|
|
SCHW
94
Charles Schwab
SCHW
$183B
| $99.2M | 0.23% |
1,570,639
-89,200
| -5% | -$6.15M |
|
95
Occidental Petroleum
OXY
$56.8B
| $98.8M | 0.23% |
1,677,248
+763,200
| +83% | +$46.9M |
|
96
Johnson Controls International
JCI
$88.8B
| $97M | 0.22% |
2,025,771
-558,183
| -22% | -$31.1M |
|
|
97
Sanofi
SNY
$103B
| $96.8M | 0.22% |
1,934,898
+1,816,898
| +1,540% | +$96.4M |
|
98
Under Armour Class C
UA
$2.77B
| $96.7M | 0.22% |
12,756,465
-6,129,190
| -32% | -$68.9M |
|
99
Sarepta Therapeutics
SRPT
$1.57B
| $94.8M | 0.22% |
1,265,000
+250,000
| +25% | +$18.4M |
|
100
ServiceNow
NOW
$115B
| $94.5M | 0.22% |
994,000
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.